Current Clinical Trials: Rheumatology analyses the competitive landscape for drugs to treat rheumatic conditions, including rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis, scleroderma and fibromyalgia. The report reviews drugs currently on the market, their competitive position, and market size and growth potential. It also analyses new drugs in Phase II and III clinical trials based on data from the leading clinical trials database, TrialTrove to give a comprehensive picture of how the market for rheumatology treatments will develop over the coming years.

The report gives a detailed analysis of:
• Primary segments of the rheumatology drugs market
• Sales data for branded products
• Clinical trials (Phases I,II and III) of new treatments and the leading sponsors
• The outlook for each segment of the market and the impact that emerging treatments are likely to have

It will help you to:
• Plan your market entry strategy
• Identify partnership/investment opportunities
• Analyse the market position of your competitors
• Identify new technologies for licensing
• Assess the competitive landscape for your products